CSIMarket
 
Sientra Inc   (SIEN)
Other Ticker:  
 
 
Price: $0.1740 $-0.04 -18.692%
Day's High: $0.202 Week Perf: -3.39 %
Day's Low: $ 0.16 30 Day Perf: -70.56 %
Volume (M): 3,435 52 Wk High: $ 4.94
Volume (M$): $ 598 52 Wk Avg: $1.76
Open: $0.19 52 Wk Low: $0.16



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 11
 Employees 400
 Revenues (TTM) (Millions $) 89
 Net Income (TTM) (Millions $) -59
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 3

Sientra Inc
Sientra Inc is a medical technology company that specializes in the development and sale of breast implants and other aesthetic products used in plastic surgery. The company was founded in 2003 and is headquartered in Santa Barbara, California.

Sientra is one of the leading providers of breast implants in the United States and is focused on providing a range of products that meet the needs of both patients and surgeons. Their products are designed to be both safe and effective, incorporating the latest technological innovations and materials to enhance patient outcomes.

One of Sientra's key products is their line of silicone breast implants, which are made from a highly cohesive, form-stable silicone gel. This advanced gel material provides a more natural look and feel than traditional saline implants, and has a lower risk of rupturing or leaking over time. Sientra also offers a range of other breast implant options, including round and shaped implants, as well as implant systems designed for tissue expanders or reconstruction after breast cancer surgery.

In addition to breast implants, Sientra also offers a range of other aesthetic products, including facial implants, body contouring implants, and other surgical devices used in plastic and reconstructive surgery. The company's products are sold through a network of authorized distributors and directly to surgeons and medical professionals.

Sientra is committed to providing high-quality products and services to its customers, and emphasizes the importance of patient safety and satisfaction in all of its operations. The company's products are subject to rigorous testing and quality assurance processes to ensure that they meet the highest standards of safety and efficacy.

Overall, Sientra Inc is a well-respected and innovative medical technology company with a strong focus on improving patient outcomes and advancing the field of plastic and reconstructive surgery. Their state-of-the-art products and commitment to quality and safety make them a reliable choice for both patients and surgeons alike.


   Company Address: 3333 Michelson Drive Irvine 92612 CA
   Company Phone Number: 562-3500   Stock Exchange / Ticker: NASDAQ SIEN
   SIEN is expected to report next financial results on April 16, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Management Announcement

Sientra Pursues Strategic Sale Through Voluntary Chapter 11 Process to Address Financial Challenges and Maximize Stakeholder Value

Published Tue, Feb 13 2024 1:30 PM UTC


Sientra, a leading medical aesthetics company, has announced its intention to pursue a strategic sale of its business through a voluntary Chapter 11 process. This decision comes as the company seeks to address its financial challenges and ensure the long-term sustainability of its operations. In order to support ongoing operations during the sale process, Sientra has su...

Sientra Inc

SIEN's Losses Mount in Q3 2023, Highlighting Financial Struggles

Sientra Inc Faces Challenges with Growing Losses but Shows Potential for Future Growth
In the financial interval closing September 30, 2023, Sientra Inc, a surgical aesthetics company, reported a substantial increase in loss per share compared to the previous year. The loss per share stood at $-1.31, compared to $-0.24 in the same quarter a year prior. Furthermore, the company saw a growth in losses from the preceding quarter, with loss per share at $-0.85.
The revenue for the same quarter declined considerably by -15.689% to $19.03 million, as opposed to $22.57 million in the same quarter a year prior. Sequentially, revenue fell by -15.857% from $22.62 million. These revenue declines indicate the challenges faced by Sientra Inc in generating profits.

Sientra Inc

Sientra Inc Announces Strong Revenue Gain, Demonstrating Solid Growth During April to June 2023



As the Stock market continues to exhibit its volatile nature, investors are constantly on the lookout for promising companies that demonstrate strong financial performance and growth prospects. In this article, we will analyze some key financial figures and market dynamics surrounding Sientra Inc, a California-based medical aesthetics company, and shed light on their recent fiscal results.
Revenue Growth and Earnings Per Share:
Sientra Inc witnessed a commendable 5.122% increase in revenue for the fiscal quarter ending June 30, 2023. The revenue jumped from $21.51 million to $22.62 million when compared to the same quarter a year ago. Moreover, the revenue saw a 0.257% sequential growth, climbing from $22.56 million.

Sientra Inc

Despite Revenue Growth, Sientra Inc Struggles with Mounting Losses in Latest Fiscal Period

Sientra Inc, a leading medical aesthetics company, recently reported their financial results for the most recent fiscal period. While the company's revenue showed growth over the past year, there was a significant increase in the deficit per share.
During the most recent fiscal period, Sientra Inc reported a deficit per share of $-1.06, compared to $-0.29 for the same period a year ago. This represents a substantial increase in the deficit per share for the company. Additionally, there was a sequential increase from the prior quarter, where the deficit per share was reported at $-0.35.






 

Sientra Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com